Literature DB >> 17289226

Humanization and mammalian expression of a murine monoclonal antibody against Venezuelan equine encephalitis virus.

Wei-Gang Hu1, Damon Chau, Josh Wu, Scott Jager, Les P Nagata.   

Abstract

The murine monoclonal antibody 1A4A1 can strongly neutralize Venezuelan equine encephalitis virus and is a good candidate for development of humanized antibody. Humanization of 1A4A1 variable domains was achieved by grafting 1A4A1 complementarity-determining regions (CDRs) onto the frameworks of human immunoglobulin germline variable and joining gene segments, whose CDRs have the highest similarities to 1A4A1 ones. The humanized 1A4A1 variable domains were further grafted onto human heavy and light chain constant domains to assemble the whole antibody gene, which was then synthesized and cloned to an adenoviral vector. After expression in HEK 293 cells and purification by protein L column, the humanized antibody was demonstrated to retain antigen-binding specificity and neutralizing activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289226     DOI: 10.1016/j.vaccine.2007.01.034

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.

Authors:  Lorena R Braid; Wei-Gang Hu; John E Davies; Les P Nagata
Journal:  Stem Cells Transl Med       Date:  2016-06-22       Impact factor: 6.940

3.  Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge.

Authors:  Natasha M Kafai; Lauren E Williamson; Elad Binshtein; Soila Sukupolvi-Petty; Christina L Gardner; Jaclyn Liu; Samantha Mackin; Arthur S Kim; Nurgun Kose; Robert H Carnahan; Ana Jung; Lindsay Droit; Douglas S Reed; Scott A Handley; William B Klimstra; James E Crowe; Michael S Diamond
Journal:  J Exp Med       Date:  2022-03-17       Impact factor: 17.579

Review 4.  Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.

Authors:  Anuj Sharma; Barbara Knollmann-Ritschel
Journal:  Viruses       Date:  2019-02-18       Impact factor: 5.048

5.  Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV.

Authors:  Amanda L Phelps; Lyn M O'Brien; David O Ulaeto; Frederick W Holtsberg; Grant C Liao; Robin Douglas; M Javad Aman; Pamela J Glass; Crystal L Moyer; Jane Ennis; Larry Zeitlin; Les P Nagata; Wei-Gang Hu
Journal:  Viruses       Date:  2021-11-05       Impact factor: 5.048

6.  Humanization and characterization of an anti-ricin neutralization monoclonal antibody.

Authors:  Wei-Gang Hu; Junfei Yin; Damon Chau; Laurel M Negrych; John W Cherwonogrodzky
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.